Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
MLTX · NASDAQ · Pharmaceutical Preparations
$11.07+0.04 (+0.36%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Moonlake Immunotherapeutics (MLTX) · oqro.io/stocks/MLTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Duquesne Family Office disclosed a new position in MLTX for Q3 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Aug 14, 2026
Weiss Asset Management LP disclosed an increased position in MLTX for Q1 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Longaeva Partners L.P. disclosed a reduced position in MLTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed an increased position in MLTX for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Weiss Asset Management LP disclosed an increased position in MLTX for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in MLTX for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Longaeva Partners L.P. disclosed a new position in MLTX for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a new position in MLTX for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
RTW Investments, LP no longer reported MLTX for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Hood River Capital Management LLC no longer reported MLTX for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP no longer reported MLTX for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Avoro Capital Advisors LLC disclosed a reduced position in MLTX for Q3 2025Fund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Avoro Capital Advisors LLC disclosed an increased position in MLTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
RTW Investments, LP disclosed a new position in MLTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in MLTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Polar Capital Holdings Plc disclosed a reduced position in MLTX for Q2 2025Insider trade · Traded Jul 3, 2025 · Filed Jul 7, 2025
Director sold ~$1.15M of MLTX shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Paradigm Biocapital Advisors LP disclosed a reduced position in MLTX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Holocene Advisors, LP disclosed a reduced position in MLTX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Hood River Capital Management LLC disclosed an increased position in MLTX for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 9, 2025
Westfield Capital Management Co LP disclosed an increased position in MLTX for Q1 2025Fund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP disclosed an increased position in MLTX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Polar Capital Holdings Plc disclosed an increased position in MLTX for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 11, 2025
Westfield Capital Management Co LP disclosed an increased position in MLTX for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Paradigm Biocapital Advisors LP disclosed a new position in MLTX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Hood River Capital Management LLC disclosed a new position in MLTX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Holocene Advisors, LP disclosed a reduced position in MLTX for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 12, 2024
Westfield Capital Management Co LP disclosed an increased position in MLTX for Q3 2024Insider trade · Traded Oct 4, 2024 · Filed Oct 8, 2024
Director sold ~$51.5M of MLTX shares in the open marketSourceInsider trade · Traded Oct 4, 2024 · Filed Oct 8, 2024
Director sold ~$41.8M of MLTX shares in the open marketSourceInsider trade · Traded Oct 4, 2024 · Filed Oct 8, 2024
Director sold ~$9.19M of MLTX shares in the open marketSourceInsider trade · Traded Oct 4, 2024 · Filed Oct 8, 2024
Director sold ~$6.63M of MLTX shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Siren, L.L.C. no longer reported MLTX for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Hood River Capital Management LLC disclosed an increased position in MLTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Siren, L.L.C. disclosed a new position in MLTX for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 12, 2025
Westfield Capital Management Co LP disclosed a reduced position in MLTX for Q2 2025Source